Tenpoint Therapeutics

Unverified

Manufacturer

Overview

Tenpoint Therapeutics is a global biotechnology company focused on vision in the aging eye. Its lead product, YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution), is a dual-agent eye drop for presbyopia approved by the FDA on January 28, 2026, and its pipeline also targets cataracts and geographic atrophy. Tenpoint is building a US field team to launch YUVEZZI with optometrists and ophthalmologists.

Hiring snapshot

Open roles

Newest first, from Tenpoint Therapeutics’s careers page.

See all 12 roles →

Divisions

Division information is pending company verification.Once Tenpoint Therapeutics claims its page, you will see each division, who it calls on and how it pays.

Claim your page

More from Tenpoint Therapeutics

These sections fill in when Tenpoint Therapeutics claims and verifies its page.

Life at Tenpoint TherapeuticsPhotos, stories and culture. Not added yet.
BenefitsNot added yet.
Is this your company? Claim your page →